Patent · US Active

Bispecific antibodies

US11325983B2 · kind B2 · utility

1Cited by

7References

9Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Prafull S. Gandhi · Rang Taché Est, DK
Jens Breinholt · Copenhagen, DK
Henrik Oestergaard · Søgård, DK

Key dates

Filing date	Oct 14, 2021
Grant date	May 10, 2022
Priority date	—
Expiry date	Oct 14, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a bispecific antibody comprising a first antigen-binding site capable of binding Factor VII(a) and a second antigen-binding site capable of binding TLT-1, pharmaceutical formulations comprising such bispecific antibodies and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.